Associate Manager For Drug R&D, Pm Division
• Actively engaged in drug in-licensing & NCE development for unmet medical needs, mainly focused on neurology & inflammatory diseases. -Over 25 in-licensing NCE/NME review for novel projects across the world within 1 year (e.g., early PoC of MOA w/ pilot Tox program, IND-enabling & Ph I/II clinical stages.) -Established a full database of unmet needs (50 Indications) from clinical & market insights for future developing direction.• Strategic coordination for PM: i.e., budgeting, business & legal/IP engagement, research & analysis of regulatory, medical, market assess to develop road maps. -A well-to-go R&D project established for unmet diseases in 1 year (e.g., animal PoC exhibited w/ lead candidate). -Oral prodrug development to improve limited drugs of choice (lead selection ongoing).